Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.1950 (-0.96%) ($7.1950 - $7.3750) on Fri. Aug. 25, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.13% (three month average) | RSI | 64 | Latest Price | $7.1950(-0.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.3% a day on average for past five trading days. | Weekly Trend | BCRX advances 2.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) UNG(48%) SMH(36%) XOP(32%) USO(29%) XLE(24%) | Factors Impacting BCRX price | BCRX will decline at least -1.565% in a week (0% probabilities). PCY(-38%) ARKK(-37%) SIL(-28%) GDX(-28%) XLY(-27%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.565% (StdDev 3.13%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.26(-0.9%) | 10 Day Moving Average | $7.15(0.63%) | 20 Day Moving Average | $7.11(1.2%) | To recent high | -18.7% | To recent low | 7.4% | Market Cap | $1.269b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |